Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival

Authors Georgeson P, Steinfelder RS, Harrison TA, et al. and Buchanan DD.
Citation medRxiv. 2024 Jan 30
PubMed Link https://pubmed.ncbi.nlm.nih.gov/37090539/
PMCID PMC10120801

Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival

Improved risk stratification scheme for mismatch repair proficient stage II colorectal cancers using the digital pathology biomarker QuantCRC

Leave a Reply Cancel reply